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trocardiogram as a prolongation of the QT interval (Ben- A Journey through the
nett et al., 1995). Species BarrierSodium channel loss-of-function defects are also a
cause of human disease. More disruptive mutations in
SCN1A that generate nonfunctional transcripts cause
severe myoclonic epilepsy of infancy (SMEI), a dominant The species barrier in prion infectivity is believed to
epilepsy syndrome that overlaps GEFS and presum- reside in the degree of amino acid sequence heterol-
ably results from haploinsufficiency (Claes et al., 2001). ogy between the infectious prion protein, PrPSc, of the
More subtle loss-of-function defects, resulting from re- donor and the normal PrP of the host. Peretz et al.
duced expression levels or altered voltage dependence (2002) bring new evidence that distinct PrPSc species
of gating, have also been implicated for idiopathic ven- or prion strains may have different conformations even
tricular fibrillation (SCN5A) and periodic paralysis (SCN4A). when they have identical amino acid sequence and
The paroxysmal nature of the symptoms in GEFS, that the conformation of the exogenous prion strain
or any of the other ion channelopathies for that matter, is a determinant of the species barrier in hosts that
remains to be adequately explained. Why does fever have identical PrP genotype.
lower seizure threshold in GEFS? What changes to
increase the susceptibility for seizures without fever The prion or protein-only hypothesis postulates that the
later in life? The interplay between genetic predisposi- pathogenic and infectious prions, PrPSc, are only made
tion and environmental triggering of symptoms is partic- of protein and derive from a normal prion protein iso-
ularly prominent in the ion channelopathies. Rest after form, PrPC (Prusiner, 1982; for general review, see Prusi-
exercise, stress, cold ambient temperature, or shifts in ner, 1999; Collinge, 2001; Gambetti et al., 2001). Forma-
serum potassium can all induce episodes of periodic tion of PrPSc involves a conformational switch by which
paralysis, myotonia, episodic ataxia, or arrhythmia. Fur- PrPC adopts the PrPSc conformation with PrPSc acting as
ther insight on how these events trigger paroxysmal template. A major challenge to this hypothesis has been
attacks will not only improve our understanding of the the existence of a wide variety of distinct prions, which
determinants of cellular excitability, but also identifies borrowing a term from virology, have been called prion
potential avenues for therapeutic intervention. strains. Another important issue related to the prion
strains is the mechanism of the species barrier—i.e.,
the degree of interspecies infectivity of a prion strainStephen C. Cannon
(Pattison, 1966). The existence of multiple prion strainsDepartment of Neurobiology
is easily explained, as are the strains of other infectiousHarvard Medical School
agents such as viruses and bacteria, by postulating theDepartment of Neurology
presence of nucleic acid in them. To fit the prion hypoth-Massachusetts General Hospital
esis, PrPSc must contain all the information to supportWellman 423/Massachusetts General Hospital
prion strain diversity and to negotiate the species bar-Boston, Massachusetts 02114
rier. The article by Peretz et al. (2002) in this issue of
Neuron addresses these issues using a new approach.Selected Reading
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Species Barrier Effect in Interspecies Trans-
mission of Distinct Prion Strains
Two distinct Syrian hamster prion strains,
Sc237 and DY, with the same amino acid se-
quence but different structural properties
transmit the disease to Tg(MH2M) mice. How-
ever, they behave quite differently in the rela-
tion to the species barrier. Upon inoculation,
Sc237 encounters the species barrier (Sp.
B.) and emerges as a different prion strain
from that present in the inoculum as indicated
by the changes in distribution of the brain
lesions (lesion profile) and PrPSc (PrPSc to-
pography) as well as in conformation. In con-
trast, the DY strain does not undergo the spe-
cies barrier effect (Sp. B) and remains
unchanged. The different behavior of Sc237
and DY strains appear to be related to their
original distinct conformations.
primary structure and the hosts are genetically iden- strains behave differently as far as the species barrier—
the Sc237 encounters a species barrier and changestical?
Peretz et al. examine two distinct Syrian hamster prion into a strain different from the original, while DY does
not. Is the conformation of PrPSc the basis of prion strainstrains, designated Sc237 and DY, that have the same
amino acid sequence (see Figure). They inoculate these diversity and species barrier effect even in the absence
of amino acid sequence heterology, as postulated bystrains to transgenic mice expressing a chimeric mouse/
hamster PrP (TgMH2M) as well as to transgenic mice the prion hypothesis? Using the conformational stability
assay to try to answer this question, Peretz et al. (2002)expressing hamster PrP and assess the incubation time
and phenotype of the diseases produced in the hosts. find a good correlation between bioassay and structural
properties of the original and passaged Sc237 and DYThe strain properties determined by this traditional
method are then correlated with data on the conforma- strains. The assay indicates that the structure of the two
original strains is different and that the conversion oftion of the two prion strains obtained with a relative
conformational stability assay. The assay, introduced the original Sc237 strain into a distinct isoform upon
inoculation to the Tg(MH2M) is associated with a changeby the same group last year, is based on the amount
of guanidine hydrochloride required to denature and in conformation, whereas under the same conditions,
no change in conformation is detected in the DY strain.render protease-sensitive the PrPSc present in the two
strains, which is protease-resistant (Peretz et al., 2001). The article by Peretz et al. (2002) elicits several consid-
erations. First, it emphasizes once more the critical roleUpon inoculation to Tg(MH2M), the two SHa prion
strains, Sc237 and DY, behaved quite differently. The of PrPSc conformation as the foundation of prion strain
diversity and species barrier as predicted by the prionoriginal Sc237 strain had a 83 day incubation time
(interval between inoculation and disease symptom ap- hypothesis. Second, it provides convincing evidence
that PrPSc conformation and species barrier may be inde-pearance), which decreased to 50 days in the second
passage—i.e., inoculation to Tg(MH2M) mice of PrPSc pendent of the primary structure of the inoculum and
the degree of homology between the PrP of the donorpreparations from Tg(MH2M) mice inoculated with
Sc237. The decrease in incubation time between first and that of the host. Third, it helps to better define the
species barrier as the inability of the host to replicateand second passage is a clear indication of species
barrier effect, as the Sc237 strains must adapt to the conformation of the inoculum, so that the barrier is
broken only by altering the inoculated prion strain andTg(MH2M) mice. In contrast, the Tg(MH2M) mice inocu-
lated with the DY prion strain showed no reduction in generating a conformationally distinct isoform. Fourth,
the choice by the host between replication and alterationincubation times between the first and second passage,
consistent with the lack of species barrier. Furthermore, (and perhaps the ability to do either) seems to depend
on the conformation of the inoculated prion strain.the disease phenotype in the Tg(MH2M) mice inoculated
with the Sc237 strain was different from that produced Of course, the issue of the interlay among conforma-
tion, prion strain diversity, and species barrier is far fromby Sc237 in hamsters, while it remained the same with
the DY strain. In additional experiments along this line, being fully clarified. A major question is the identity of
the structural properties that determine the reproducibil-Peretz et al. also inoculated back to hamsters (or Tg
mice expressing hamster PrPC) the Tg(MH2M)-passaged ity (or lack thereof) of a prion strain in a given host. In
other words, which structural properties make it possi-Sc237 and DY strains and confirmed that while the
mouse-passaged Sc237 strain was distinct from the ble for a prion strain to cross the species barrier? Know-
ing these properties would provide the Rosetta stoneoriginal hamster Sc237 strain, the DY strain had not
changed. The two major conclusions of these complex to separate livestock-associated prion strains that can
cross the human barrier from those that cannot. Afterstudies based on the traditional bioassay approach are
that (1) the two original hamster prion strains are distinct, having spent quite a bit of time at considerable cost to
gather evidence that the prion strain associated withalthough they have an identical primary structure, and
(2) upon inoculation to syngenic receptive mice, the two bovine spongiform encephalopathy is likely to cross the
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human barrier, it would now be very useful to know interspecies prion transmission is staggering and may
quickly whether a similar event may occur for the prion also depend on other factors, namely route of infection,
strains of deer and elk affected by the prion diseases PrP glycosylation, and other proteins interacting with
called chronic wasting disease (CWD), which is endemic PrP. Exciting and unexpected findings are likely to be
in parts of the United States. The answer to this question forthcoming. Stay tuned.
is of obvious relevance to public health. Another ques-
tion is the role of the glycans linked to PrPSc in prion
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undetectable in one-dimensional gel electrophoresis
(Pan et al., 2001). The other two are conformational
assays including the conformational stability test used
by Peretz at al. (2002) (Safar et al., 1998; Peretz et al.,
2001). Although it is unquestionably powerful, the con- Adult Neurogenesis
formational assay used by Peretz et al. (2002) also seems and the Vascular Nietzsche
to have limitations. For example, following a passage in
the Tg(MH2M) mouse, the structural measurements of
the Sc237 strain as determined by this assay become
similar to those of DY strain, although the two strains Adult neurogenesis is mediated by immature neural
are different by bioassay and by gel typing since Sc237 precursors that divide within the residual germinal ma-
and DY remain of type 1 and 2, respectively, through trices of the brain. In the paper by Louissaint et al.
the passages in the Tg(MH2M) mice. Because the insolu- (2002) in this issue of Neuron, the “cause and effect”
bility and tendency to aggregate currently make the di- of adult neurogenesis takes a major step forward with
rect study of the three-dimensional structure of prion the description of a vascular signaling network that
strains impossible, it is most likely that the best ap- influences neuronal precursor migration and fate.
proach to examine the structural properties of the prion
“Cause and effect: there is probably never any suchstrains will be the use of multiple assays rather than
duality; in fact there is a continuum before us, fromone assay only. By using a combination of the available
which we isolate a few portions…. The suddenness withassays and new ones that will be undoubtedly devel-
which many effects stand out misleads us; actually, it isoped in the future, we may shed light on the molecular
sudden only for us. In this moment of suddenness theremechanisms underlying the changes in the PrPSc confor-
are an infinite number of processes which elude us.”mation that then determine prion strain diversity and
—Nietzsche, 1882interspecies transmission.
The level of complexity of PrPSc conformation and Translated from “The Gay Science”, section 112
